New Quiet Initiative To Improve Drug Access In Middle-Income Countries, Change Country Classification System 25/02/2015 by Catherine Saez, Intellectual Property Watch 2 Comments This week a confidential high-level expert meeting was convened in Geneva to start work on a potential change in the country classification used by global health actors to remedy the growing problem of access to medicines in middle-income countries.
WIPO Members Propose Changes To Draft Legal Instrument Protecting GIs 24/02/2015 by Catherine Saez, Intellectual Property Watch 1 Comment In the run-up to the May high-level negotiating meeting to amend a World Intellectual Property Organization treaty to enhance the protection of geographical indications, member countries were invited to suggest changes to the basic negotiating text. Ten countries issued proposed changes by the 1 February deadline, some asking for full participation of WIPO members in the negotiations of the 28-member treaty.
Status Of WTO Wines And Spirits Register Discussed 24/02/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment World Trade Organization delegates were convened this week to discuss an international register for wines and spirits in the context of the organisation’s agreement on intellectual property. The discussion, dating back nearly 20 years, has long involved different views on the register, which were reaffirmed this week, according to sources in Geneva.
In 21st Century No One Should Die For Lack Of Access To Medicines, Participants At UN Forum Say 23/02/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment Last week’s 2015 Social Forum led by the UN Office of the High Commissioner for Human Rights (OHCHR) called for urgent action to facilitate access to medicines. In particular, the functioning of the intellectual property system was put into question. A number of recommendations were drawn by the secretariat after having been identified by participants.
TRIPS In Question During Social Forum Discussion On Access To Medicines 23/02/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment Intellectual property rights are hindering access to medicines by maintaining monopolies and high prices, according to speakers at an annual United Nations forum on human rights last week. Flexibilities enshrined in the World Trade Organization intellectual property agreement are hampered by political and economical pressure, they said, and a new system should be devised for pharmaceutical products.
Neuchâtel Event Looks At Swiss Innovation, Competitiveness 20/02/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment NEUCHATEL – Switzerland is among the best students of global innovation. It continues to score at the top of global indexes and reports on innovation and competitiveness. At a seminar last week at the University of Neuchâtel, speakers gave their views on that success.
WIPO Seminar Could Rekindle Discussions On Genetic Resources, TK 20/02/2015 by Catherine Saez, Intellectual Property Watch 1 Comment After the failure to agree on work to be done by the World Intellectual Property Organization committee on genetic resources and traditional knowledge at the last general assembly, and a barren calendar of meetings on the subject, WIPO is organising a seminar aimed at sharing regional, national and local experiences.
At WTO Next Week: GI Register, Plain Packaging, Women In Innovation 19/02/2015 by Catherine Saez, Intellectual Property Watch 1 Comment The next meeting of the World Trade Organization intellectual property committee is expected to include discussions on women and innovation, and concerns about legislative efforts in the United Kingdom and Ireland to introduce plan packaging for tobacco products. Prior to the meeting, informal consultations will be held on the negotiating issue of an international register for geographical indications (GIs) for wines and spirits.
The Year In Biotech/Biodiversity: Patentability, Plant Varieties, Treaty Implementation 16/02/2015 by Catherine Saez, Intellectual Property Watch 1 Comment Intellectual property-related developments expected this year could profoundly impact the fields of biotechnology and biodiversity. In addition, ongoing issues relating to plant variety protection and public health are expected to be at the forefront of discussions this year. The following is a look at many of the top issues to come.
US Challenges For Biotech In 2015 – An Interview With BIO’s Hans Sauer 06/02/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment The biotechnology industry is closely watching developments in the United States that could impact the industry in 2015. These include the regulatory framework for biosimilars, possible patent legislation, post-grant review procedure, and the consequences of the recent Supreme Court ruling banning the patenting of human genes. Hans Sauer, Deputy General Counsel for Intellectual Property at the Biotechnology Industry Organization (BIO), recently spoke with Intellectual Property Watch’s Catherine Saez. Sauer was asked to lay out the main developments to watch in the coming year.